Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)

Clinical trial NCT02781480 · COMPLETED

Trial details

NCT number: NCT02781480
Sponsor: MeiraGTx UK II Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leber Congenital Amaurosis

Start date: 2016-04-01
Primary completion: 2018-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.